Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wei Li Bai Capsules in Mild to Moderate Alzheimer's Disease
NCT05670912Phase 2Terminated
- Sponsor
- Capital Medical University
- Start
- Oct 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Wei Li Bai in Alzheimer's disease (AD), sponsored by Capital Medical University. Started Oct 2022; status: terminated.
02
Drugs
Wei Li Bai
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05670912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05670912.